174 related articles for article (PubMed ID: 28263073)
1. Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers.
Fan W; Zhang W; Jia Y; Brusnahan SK; Garrison JC
Mol Pharm; 2017 May; 14(5):1405-1417. PubMed ID: 28263073
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer.
Fan W; Shi W; Zhang W; Jia Y; Zhou Z; Brusnahan SK; Garrison JC
Biomaterials; 2016 Oct; 103():101-115. PubMed ID: 27372424
[TBL] [Abstract][Full Text] [Related]
3. The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging.
Shi W; Ogbomo SM; Wagh NK; Zhou Z; Jia Y; Brusnahan SK; Garrison JC
Biomaterials; 2014 Jul; 35(22):5760-70. PubMed ID: 24755528
[TBL] [Abstract][Full Text] [Related]
4. 177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model.
Ogbomo SM; Shi W; Wagh NK; Zhou Z; Brusnahan SK; Garrison JC
Nucl Med Biol; 2013 Jul; 40(5):606-17. PubMed ID: 23622691
[TBL] [Abstract][Full Text] [Related]
5. Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of
Wagener K; Moderegger D; Allmeroth M; Reibel A; Kramer S; Biesalski B; Bausbacher N; Zentel R; Thews O; Rösch F
Nucl Med Biol; 2018 Mar; 58():59-66. PubMed ID: 29413458
[TBL] [Abstract][Full Text] [Related]
6. P(HPMA)-block-P(LA) copolymers in paclitaxel formulations: polylactide stereochemistry controls micellization, cellular uptake kinetics, intracellular localization and drug efficiency.
Barz M; Armiñán A; Canal F; Wolf F; Koynov K; Frey H; Zentel R; Vicent MJ
J Control Release; 2012 Oct; 163(1):63-74. PubMed ID: 22613881
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Evaluation and Biodistribution Studies of HPMA Copolymers Targeting the Gastrin Releasing Peptide Receptor in Prostate Cancer.
Alshehri S; Fan W; Zhang W; Garrison JC
Pharm Res; 2020 Oct; 37(11):229. PubMed ID: 33098043
[TBL] [Abstract][Full Text] [Related]
8. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers.
Oupický D; Konák C; Ulbrich K; Wolfert MA; Seymour LW
J Control Release; 2000 Mar; 65(1-2):149-71. PubMed ID: 10699278
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line BR; Mitra A; Nan A; Ghandehari H
J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
[TBL] [Abstract][Full Text] [Related]
10. A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer.
Chandran SS; Nan A; Rosen DM; Ghandehari H; Denmeade SR
Mol Cancer Ther; 2007 Nov; 6(11):2928-37. PubMed ID: 18025277
[TBL] [Abstract][Full Text] [Related]
11. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
[TBL] [Abstract][Full Text] [Related]
12. PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: a quantitative study using radiolabeling and positron emission tomography.
Allmeroth M; Moderegger D; Gündel D; Buchholz HG; Mohr N; Koynov K; Rösch F; Thews O; Zentel R
J Control Release; 2013 Nov; 172(1):77-85. PubMed ID: 23954630
[TBL] [Abstract][Full Text] [Related]
13. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
14. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.
Buckway B; Wang Y; Ray A; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):202-11. PubMed ID: 23933441
[TBL] [Abstract][Full Text] [Related]
16. DNA complexes with block and graft copolymers of N-(2-hydroxypropyl)methacrylamide and 2-(trimethylammonio)ethyl methacrylate.
Oupický D; Konák C; Ulbrich K
J Biomater Sci Polym Ed; 1999; 10(5):573-90. PubMed ID: 10357267
[TBL] [Abstract][Full Text] [Related]
17. Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells.
Mohr N; Kappel C; Kramer S; Bros M; Grabbe S; Zentel R
Nanomedicine (Lond); 2016 Oct; 11(20):2679-2697. PubMed ID: 27628185
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
Li L; Yang Q; Zhou Z; Zhong J; Huang Y
Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
[TBL] [Abstract][Full Text] [Related]
19. The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells.
David A; Kopecková P; Kopecek J; Rubinstein A
Pharm Res; 2002 Aug; 19(8):1114-22. PubMed ID: 12240936
[TBL] [Abstract][Full Text] [Related]
20. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics.
Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R
J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
